Live
Lonza NewsStarLIMS: MODA Platform Acquisition From Lonza To Expand Manufacturing And Quality Control Capabilities - Pulse 2.0FierceBiotechScientists turn pig semen extract into eye drops that kill cancer in miceEndpoints NewsOtsuka buys Transcend Therapeutics for $700M upfrontEndpoints NewsCHMP recommends subcutaneous form of Sanofi's Sarclisa and four new drugsBioWorldBiopharma money raised: Jan. 1-March 26, 2026BioWorldMoney raised by biopharmaBioPharma DiveOtsuka picks up PTSD drug with $700M Transcend buyLonza NewsLonza Media Development Lab Set Up in Singapore - Genetic Engineering and Biotechnology NewsFierceBiotech'We need to put some bad ideas to bed': Inside Incubate's battles for biotech on Capitol HillFierceBiotechAfter local tumor approval, Novocure touts positive data in metastatic pancreatic cancerFierceBiotechOtsuka buys Transcend in $1.2B deal, nabbing MDMA analog for psychiatric conditionsFierceBiotechAstraZeneca’s in vivo CAR-T bet eradicates cancer in 3 of 5 patients, but death mars dataset
Endpoints News Mar 26, 2026

Kodiak’s Phase 3 eye drug success; Innate discontinues anti-CD20 program

Kodiak’s Phase 3 eye drug success; Innate discontinues anti-CD20 program

Original
Body unavailable. Use the original source.

Directory

59 All